Cite
Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis.
MLA
Kaur, Daljeet, et al. “Impact of the Inflammation on the Outcomes of Catheter Ablation of Drug-Refractory Ventricular Tachycardia in Cardiac Sarcoidosis.” Journal of Cardiovascular Electrophysiology, vol. 31, no. 3, Mar. 2020, pp. 612–20. EBSCOhost, https://doi.org/10.1111/jce.14341.
APA
Kaur, D., Roukoz, H., Shah, M., Yalagudri, S., Pandurangi, U., Chennapragada, S., & Narasimhan, C. (2020). Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis. Journal of Cardiovascular Electrophysiology, 31(3), 612–620. https://doi.org/10.1111/jce.14341
Chicago
Kaur, Daljeet, Henri Roukoz, Mandar Shah, Sachin Yalagudri, Ulhas Pandurangi, Sridevi Chennapragada, and Calambur Narasimhan. 2020. “Impact of the Inflammation on the Outcomes of Catheter Ablation of Drug-Refractory Ventricular Tachycardia in Cardiac Sarcoidosis.” Journal of Cardiovascular Electrophysiology 31 (3): 612–20. doi:10.1111/jce.14341.